On August 4, Hanyu Pharmaceutical (300199.SZ) rose its daily limit in the afternoon, quoting 24.32 yuan, and the stock price hit a new high since December 2022.
On the news, Hanyu Pharmaceutical and digital asset platform Ku Coin officially signed a letter of intent for strategic cooperation. The two parties plan to jointly explore the first RWA (Re al Wo rld Aset) tokenization pilot project in Hong Kong with the "future income right of innovative drug research and development" as the underlying asset.
According to the agreement, Hanyu Pharmaceutical will use its technology accumulation and R & D pipeline in the field of GLP-1 peptide blockbuster drugs as the base asset, and Ku Coin will leverage its advantages in blockchain technology, RWA full-process solutions and global compliance resources to provide on-chain mapping, asset tokenization, transaction matching, income distribution and other integrated support for the project. (Gronghui)
Hanyu Pharmaceutical and digital asset platform Ku C o in signed a letter of intent for strategic cooperation, and the share price rose by the daily limit
2025-08-04 06:43:48
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
翰宇药业与数字资产平台KuCoin签署战略合作意向书，股价拉升涨停Next article：
持仓BNB 9个月地址向币安转入4759枚BNB，预计将获利59.1万美元
